Siemens Healthineers AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000SHL1006
EUR
35.76
-0.56 (-1.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
5,402.00
6,322.00
5,662.00
5,909.00
5,482.00
6,329.00
5,423.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,402.00
6,322.00
5,662.00
5,909.00
5,482.00
6,329.00
5,423.00
Raw Material Cost
3,326.00
3,948.00
3,481.00
3,586.00
3,330.00
3,921.00
3,333.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
96.00
108.00
104.00
104.00
108.00
142.00
116.00
Selling and Distribution Expenses
876.00
937.00
816.00
943.00
940.00
635.00
918.00
Other Expenses
38.00
39.10
38.90
38.10
37.30
35.40
36.80
Total Expenditure (Excl Depreciation)
4,678.00
5,384.00
4,790.00
5,014.00
4,751.00
5,052.00
4,735.00
Operating Profit (PBDIT) excl Other Income
724
938
872
895
731
1277
688
Other Income
25.00
-12.00
99.00
-11.00
26.00
36.00
23.00
Operating Profit (PBDIT)
1,047.00
1,234.00
1,341.00
1,196.00
1,062.00
1,622.00
1,006.00
Interest
96.00
108.00
104.00
104.00
108.00
142.00
116.00
Exceptional Items
-49.00
-38.00
-131.00
-48.00
-33.00
-327.00
0.00
Gross Profit (PBDT)
2,076.00
2,374.00
2,181.00
2,323.00
2,152.00
2,408.00
2,090.00
Depreciation
298.00
308.00
370.00
312.00
305.00
309.00
295.00
Profit Before Tax
603.00
780.00
736.00
731.00
617.00
844.00
595.00
Tax
147.00
173.00
180.00
193.00
139.00
220.00
123.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
450.00
588.00
552.00
530.00
474.00
617.00
468.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
450.00
588.00
552.00
530.00
474.00
617.00
468.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.00
9.00
4.00
7.00
4.00
7.00
4.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
456.00
597.00
556.00
537.00
478.00
624.00
472.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
18,429.00
18,040.00
17,677.00
18,668.00
19,777.00
18,199.00
18,236.00
Earnings per share (EPS)
0.4
0.53
0.49
0.47
0.42
0.55
0.42
Diluted Earnings per share
0.4
0.53
0.49
0.47
0.42
0.55
0.42
Operating Profit Margin (Excl OI)
13.4%
14.84%
15.4%
15.15%
13.33%
20.18%
12.69%
Gross Profit Margin
16.68%
17.21%
19.53%
17.65%
16.82%
18.22%
16.41%
PAT Margin
8.33%
9.3%
9.75%
8.97%
8.65%
9.75%
8.63%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is -1.46% vs 5.91% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -4.60% vs 10.65% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -1.35% vs 9.98% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -11.11% vs 0.93% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Siemens Healthineers AG With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
5,402.00
5,070.00
332.00
6.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,402.00
5,070.00
332.00
6.55%
Raw Material Cost
3,326.00
3,681.00
-355.00
-9.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
96.00
99.00
-3.00
-3.03%
Selling and Distribution Expenses
876.00
772.02
103.98
13.47%
Other Expenses
38.00
-6.00
44.00
733.33%
Total Expenditure (Excl Depreciation)
4,678.00
4,492.02
185.98
4.14%
Operating Profit (PBDIT) excl Other Income
724.00
577.98
146.02
25.26%
Other Income
25.00
32.02
-7.02
-21.92%
Operating Profit (PBDIT)
1,047.00
983.00
64.00
6.51%
Interest
96.00
99.00
-3.00
-3.03%
Exceptional Items
-49.00
-44.00
-5.00
-11.36%
Gross Profit (PBDT)
2,076.00
1,389.00
687.00
49.46%
Depreciation
298.00
373.00
-75.00
-20.11%
Profit Before Tax
603.00
467.00
136.00
29.12%
Tax
147.00
106.00
41.00
38.68%
Provisions and contingencies
0
0
0.00
Profit After Tax
450.00
327.00
123.00
37.61%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
450.00
327.00
123.00
37.61%
Share in Profit of Associates
0
0
0.00
Minority Interest
6.00
76.00
-70.00
-92.11%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
456.00
403.00
53.00
13.15%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
18,429.00
13,309.83
5,119.17
38.46%
Earnings per share (EPS)
0.40
1.14
-0.74
-64.91%
Diluted Earnings per share
0.40
1.14
-0.74
-64.91%
Operating Profit Margin (Excl OI)
13.40%
11.40%
0.00
2.00%
Gross Profit Margin
16.68%
16.57%
0.00
0.11%
PAT Margin
8.33%
6.45%
0.00
1.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 540.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -14.55% vs 11.66% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -1.46% vs 5.91% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 45.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -23.62% vs 7.37% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -4.60% vs 10.65% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 102.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -17.98% vs 0.32% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -1.35% vs 9.98% in Dec 2024

Quarterly - Interest
Interest 9.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -11.11% vs 3.85% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -11.11% vs 0.93% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.40%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024